Načítá se...
NAT2 slow acetylation and GSTM1 null genotypes increase bladder cancer risk: results from the Spanish Bladder Cancer Study and meta-analyses
Background: Many associations between common genetic polymorphisms and complex diseases have not been replicated. One of the few exceptions may be the association between NAT2 slow acetylation, GSTM1 null genotype and bladder cancer risk. However, current evidence is based on meta-analyses of relati...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2005
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1459966/ https://ncbi.nlm.nih.gov/pubmed/16112301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(05)67137-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|